摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-氯-1,3-二氢-1-甲基-5-苯基-2H-苯并-1,4-二氮杂卓-2-酮单盐酸盐 | 52468-36-7

中文名称
7-氯-1,3-二氢-1-甲基-5-苯基-2H-苯并-1,4-二氮杂卓-2-酮单盐酸盐
中文别名
(2S-(2α,4α,5α,6β))-3,3-二甲基-7-羰基-6-(N-苯乙酰氨基)-4-硫杂-1-氮杂二环(3.2.0)庚烷-2-羧酸4-氧化
英文名称
Diazepam hydrochloride
英文别名
7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one;hydron;chloride
7-氯-1,3-二氢-1-甲基-5-苯基-2H-苯并-1,4-二氮杂卓-2-酮单盐酸盐化学式
CAS
52468-36-7
化学式
C16H13ClN2O*ClH
mdl
——
分子量
321.206
InChiKey
BPYZIOINRAWEQL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.58
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    32.7
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • CHROMATOGRAPHIC METHOD FOR COLLECTING BLOOD COAGULATION FACTOR VII WITH HIGH YIELD
    申请人:KM Biologics Co., Ltd.
    公开号:EP3560946A1
    公开(公告)日:2019-10-30
    A chromatographic method for collecting blood coagulation factor VII (Factor VII) and/or activated blood couagulation factor VII (activated Factor VII) from plasma-derived fractions with high yield is provided. In accordance with the method of the present invention, Factor VII and/or activated Factor VII of interest can be collected with a recovery rate of as high as 90% or more by letting Factor VII and/or activated Factor VII which fails to be adsorbed to a first anion exchange resin and remains in a non-adsorption fraction be adsorbed in a second anion exchange resin.
    本发明提供了一种从血浆衍生馏分中高产率收集血凝因子 VII(因子 VII)和/或活化血凝因子 VII(活化因子 VII)的色谱方法。根据本发明的方法,通过让未能吸附在第一阴离子交换树脂上并留在非吸附馏分中的因子 VII 和/或活化因子 VII 吸附在第二阴离子交换树脂上,可收集到有关因子 VII 和/或活化因子 VII,回收率高达 90% 或更高。
  • Chromatographic method for collecting blood coagulation factor VII with high yield
    申请人:KM Biologics Co., Ltd.
    公开号:US11059857B2
    公开(公告)日:2021-07-13
    A chromatographic method for collecting blood coagulation factor VII (Factor VII) and/or activated blood coagulation factor VII (activated Factor VII) from plasma-derived fractions with high yield is provided. In accordance with the method of the present invention, Factor VII and/or activated Factor VII of interest can be collected with a recovery rate of as high as 90% or more by letting Factor VII and/or activated Factor VII which fails to be adsorbed to a first anion exchange resin and remains in a non-adsorption fraction be adsorbed in a second anion exchange resin.
    本发明提供了一种从血浆衍生馏分中高产率收集血凝因子 VII(因子 VII)和/或活化血凝因子 VII(活化因子 VII)的色谱方法。根据本发明的方法,通过让未能吸附在第一阴离子交换树脂上并留在非吸附馏分中的因子 VII 和/或活化因子 VII 吸附在第二阴离子交换树脂上,可收集到有关因子 VII 和/或活化因子 VII,回收率高达 90% 或更高。
  • PROPHYLACTIC EFFICACY OF SEROTONIN 4 RECEPTOR AGONISTS AGAINST STRESS
    申请人:The Trustees of Columbia University in the City of New York
    公开号:EP3952852A1
    公开(公告)日:2022-02-16
  • SYSTEMS AND METHODS FOR SYNTHESIZING CHEMICAL PRODUCTS, INCLUDING ACTIVE PHARMACEUTICAL INGREDIENTS
    申请人:Massachusetts Institute of Technolohy
    公开号:US20180207604A1
    公开(公告)日:2018-07-26
    Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients, are provided. Certain of the systems and methods described herein are capable of manufacturing multiple chemical products without the need to fluidically connect or disconnect unit operations when switching from one making chemical product to making another chemical product.
  • US6908915B1
    申请人:——
    公开号:US6908915B1
    公开(公告)日:2005-06-21
查看更多